Xilio Therapeutics Inc. Gains 41.67%
Mon, Apr 01, 2024 at 07:11 PM
Xilio Therapeutics Inc. (XLO:NASDAQ) soared at $1.53, representing a gain of 41.7%. On Mon, Apr 01, 2024, XLO:NASDAQ hit a New 2-Week High of $1.53. The stock got featured on our News Catalysts scanner on Mon, Apr 01, 2024 at 05:17 PM in the 'EARNINGS' category. From Mon, Mar 18, 2024, the stock recorded 55.56% Up Days and 30.00% Green Days
The stock spiked on Thu, Mar 28, 2024 at $1.93 with a volume of 34M+.
About Xilio Therapeutics Inc. (XLO:NASDAQ)
Xilio Therapeutics Inc is a biotechnology company focused on harnessing the immune system to achieve deep and durable clinical responses to improve the lives of patients with cancer.
Top 10 Gainers:
- Vast Renewables Limited (VSTE:NASDAQ), 157.61%
- CXApp Inc. Class A Common Stock (CXAI:NASDAQ), 151.02%
- Vinco Ventures Inc. (BBIG:NASDAQ), 87.5%
- two Class A (TWOA:NYSE), 71.47%
- Mediaco Holding Inc. (MDIA:NASDAQ), 55.47%
- Xilio Therapeutics Inc. (XLO:NASDAQ), 41.67%
- IM Cannabis Corp. (IMCC:NASDAQ), 40.02%
- SPAR Group, Inc. (SGRP:NASDAQ), 39.23%
- Tempest Therapeutics Inc. (TPST:NASDAQ), 39.13%
- Matinas BioPharma Holdings, Inc. (MTNB:NYSEMKT), 36.46%